Active Motif and Arima reached an agreement that expands Active Motif’s research genomics portfolio while supporting Arima’s strategic focus on its clinical diagnostics platform. The announcement does not provide deal size or financial impact in the provided excerpt, so likely near-term market impact is limited.
Active Motif and Arima reached an agreement that expands Active Motif’s research genomics portfolio while supporting Arima’s strategic focus on its clinical diagnostics platform. The announcement does not provide deal size or financial impact in the provided excerpt, so likely near-term market impact is limited.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
